Table 2.
All adverse events regardless of attribution (N = 20 patients).
| Adverse events, n (%) | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
|---|---|---|---|---|
| Anemia | 1 (5) | 4 (20) | 5 (25) | 1 (5) |
| Fatigue | 5 (25) | 5 (25) | 3 (15) | |
| Neutropenia | 6 (30) | 3 (15) | ||
| Thrombocytopenia | 3 (15) | 2 (10) | ||
| Peripheral sensory neuropathy | 1 (5) | 2 (10) | ||
| Lymphopenia | 1 (5) | 2 (10) | ||
| Diarrhea | 3 (15) | 1 (5) | ||
| Decreased ejection fraction | 1 (5) | |||
| Hypokalemia | 1 (5) | |||
| Pneumonia | 1 (5) | |||
| Noncardiac chest pain | 1 (5) | |||
| Pain | 1 (5) | |||
| Pericardial effusion∗ | 1 (5) | |||
| Pericardial tamponade∗ | 1 (5) | |||
| Pericarditis∗ | 1 (5) | |||
| Pulmonary embolism | 1 (5) | |||
| Syncope | 1 (5) | |||
| Vomiting | 4 (20) | 1 (5) | ||
| Leukopenia | 1 (5) | 2 (10) | ||
| Biopsy-related bleeding | 1 (5) |
∗Grade 3 pericardial effusion, tamponade, and pericarditis all occurred in the same patient.